bisoprolol
Selected indexed studies
- Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review. (Ann Pharm Fr, 2022) [PMID:35093388]
- Pharmacogenetic polymorphisms affecting bisoprolol response. (Biomed Pharmacother, 2021) [PMID:34470728]
- Bisoprolol: A comprehensive profile. (Profiles Drug Subst Excip Relat Methodol, 2021) [PMID:33461700]
_Worker-drafted node — pending editorial review._
Connections
bisoprolol is a side effect of
Sources
- Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review. (2022) pubmed
- Pharmacogenetic polymorphisms affecting bisoprolol response. (2021) pubmed
- Bisoprolol: A comprehensive profile. (2021) pubmed
- Bisoprolol: is this just another beta-blocker for hypertension or angina? (1995) pubmed
- Bisoprolol: a review of its use in chronic heart failure. (2002) pubmed
- Bisoprolol: a new beta-adrenoceptor blocking drug. (1987) pubmed
- Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications. (2019) pubmed
- Efficacy and Safety of Bisoprolol in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. (2023) pubmed
- Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT. (2025) pubmed
- Bisoprolol for congestive heart failure. (2008) pubmed